• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Synageva BioPharma Corp

+ Add to Watchlist

GEVA:US

64.8300 USD 0.5600 0.86%

As of 20:10:00 ET on 09/16/2014.

Snapshot for Synageva BioPharma Corp (GEVA)

Open: 64.9700 Day's Range: 63.7700 - 65.3300 Volume: 212,396
Previous Close: 65.3900 52wk Range: 44.5400 - 119.4200 1-Yr Rtn: +23.39%

Stock Chart for GEVA

No chart data available.
  • GEVA:US 64.8300
  • 1D
  • 1M
  • 1Y
65.3900
Interactive GEVA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GEVA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -4.7000
Est. EPS (USD) (12/2014) -6.1200
Est. PEG Ratio -
Market Cap (M USD) 2,150.12
Shares Outstanding (M) 33.17
30 Day Average Volume 236,691
Price/Book (mrq) 3.8345
Price/Sale (ttm) 228.0682
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 5.0000
Dividend Ex-Date 12/30/2008
5 Year Dividend Growth -
Next Earnings Announcement 10/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GEVA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GEVA

Synageva BioPharma Corp. is a clinical stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need.

Sanj K PatelPresident/CEO/SecretaryCarsten BoessSenior VP/CFO
Glen WilliamsSenior VP:Global Technical OpsMarc E GoldbergSenior VP:Product Dev
More Company Profile & Key Executives for GEVA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil